Perspectives on benefits and risks of creation of an “injection drug use” billing code

By sjmartinez • May 13, 2024

Sundaram G, Sato T, Goodman-Meza D, Haddad M, Thakarar K, Feinberg J, Springer SA, Barton K, Butler N, Eaton EF, Wurcel AG. Perspectives on benefits and risks of creation of an "injection drug use" billing code. J Subst Use Addict Treat. 2024 May 10:209392. doi: 10.1016/j.josat.2024.209392. Epub ahead of print. PMID: 38735482.

Tags: Infectious Diseases, Publications

Climate Change and Coccidioidomycosis

Lee PS, Swain DL, Johnson R. Climate Change and Coccidioidomycosis. JAMA. 2025 Feb 20. doi: 10.1001/jama.2024.27274. Epub ahead of print. PMID: 39976999.

Leronlimab Treatment for Multidrug-Resistant HIV-1 (OPTIMIZE): a Randomized, Double-Blind, Placebo-Controlled Trial

Gathe JC, Dejesus E, Ramgopal MN, Rolle CP, Yang OO, Sanchez WE, Lalezari JP, Krishen A, Sacha JB, Hansen SG, Meidling J. Leronlimab Treatment for[...]

Leptospirosis-Improving Healthcare Outcomes for a Neglected Tropical Disease

Muñoz-Zanzi C, Dreyfus A, Limothai U, Foley W, Srisawat N, Picardeau M, Haake DA. Leptospirosis-Improving Healthcare Outcomes for a Neglected Tropical Disease. Open Forum Infect[...]